Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease.

CPT Pharmacometrics Syst Pharmacol · 2024 · PMC11646937 · PMID 39207112

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

For the final PK model, goodness‐of‐fit plots did not indicate systematic model deficiencies (Figure S2 ), except for a slight trend in CWRES in Study 101 for which the reason is unknown.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.